Table 3.
Patient population details for study participants with cancer. The row highlighted grey corresponds to the one subject with cancer who reached the endpoint of death.
| Sex | Age | Antihistamine | Cancer |
|---|---|---|---|
| M | 88 | Ebastine | Prostate |
| M | 86 | Dexchlorpheniramine | Prostate |
| F | 83 | Dexchlorpheniramine | Breast |
| M | 80 | Dexchlorpheniramine | Colon |
| M | 71 | Cetirizine | Prostate |
| M | 70 | Dexchlorpheniramine | Colon |
| F | 65 | Dexchlorpheniramine | Breast |
| F | 64 | Ebastine | Breast |
| M | 59 | Cetirizine | Prostate |
| M | 58 | Cetirizine | Gastric |
| M | 56 | Cetirizine | Prostate |
| F | 46 | Levocetirizine | Breast |
| F | 23 | Cetirizine | Breast |